Browse Category

Investing News 30 December 2025

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

NEW YORK, December 30, 2025, 14:45 ET — Regular session Arcutis Biotherapeutics shares fell 2.9% to $27.74 in afternoon trading on Tuesday, after moving between $27.72 and $28.65. Volume was about 0.6 million shares. The drop outpaced broader biotech gauges, with the SPDR S&P Biotech ETF down about 1.5% and the iShares Nasdaq Biotechnology ETF off about 1.1%. That matters for Arcutis because it trades as a growth story tied to one product franchise, leaving the stock prone to outsized moves when sentiment sours across biotech and high-multiple names. Arcutis is a commercial-stage medical dermatology company whose main product, Zoryve
Vera Therapeutics stock drops 3% today as biotech slips into year-end trading

Vera Therapeutics stock drops 3% today as biotech slips into year-end trading

NEW YORK, December 30, 2025, 2:26 PM ET — Regular session Vera Therapeutics, Inc. shares slid 3.4% to $50.45 in afternoon trading on Tuesday, giving back some recent gains as biotech stocks softened late in the year. The move matters now because Vera has become a bellwether “event-driven” biotech name, where day-to-day trading can swing sharply as investors calibrate risk around FDA timelines and competitive positioning in kidney disease. Thin year-end liquidity can amplify those swings, and traders have been quick to trim exposure to smaller, higher-beta healthcare names when the sector loses momentum. Minutes from the Federal Reserve’s December
Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

Rigetti stock today: RGTI steadies as Fed minutes and year-end flows keep quantum names jumpy

NEW YORK, December 30, 2025, 14:34 ET — Regular session Rigetti Computing shares edged up 0.3% to $22.34 on Tuesday afternoon, after swinging about 3% between the day’s high and low. IonQ rose 1.2% and D-Wave Quantum gained 1.6%. The muted move matters because quantum-computing stocks have become a high-beta pocket of the market, prone to sudden swings when liquidity thins and rate expectations shift. With the calendar turning, traders are re-pricing how much room the Federal Reserve has to ease in 2026. U.S. stocks were subdued in holiday-thin trading, with investors rotating within technology after a late-year run-up, Reuters
AT&T stock today ticks higher as Fed minutes loom and year-end rotation lifts telecoms

AT&T stock today ticks higher as Fed minutes loom and year-end rotation lifts telecoms

NEW YORK, December 30, 2025, 14:35 ET — Regular session AT&T Inc shares were up 0.1% at $24.80 in afternoon trade on Tuesday, hovering near the top of a tight day range as the broader market struggled for direction. The stock traded between $24.75 and $24.85. The move matters because income-heavy telecom stocks often trade with interest-rate expectations at year-end, when many investors rebalance portfolios. The yield on the 10-year U.S. Treasury note rose 1.8 basis points — a basis point is 0.01 percentage point — to 4.134%, and traders were awaiting the Federal Reserve’s meeting minutes later in the
PayPal stock slips in late trade after Fed minutes; here’s what PYPL investors are watching next

PayPal stock slips in late trade after Fed minutes; here’s what PYPL investors are watching next

NEW YORK, December 30, 2025, 14:33 ET — Regular session PayPal Holdings (PYPL.O) shares were down about 0.6% at $59.14 in afternoon trading on Tuesday, after the Federal Reserve’s latest meeting minutes sharpened the debate over where interest rates go next. The move matters because liquidity is thin into year-end, when smaller trades can have an outsized impact on price. For consumer-facing fintech names like PayPal, rate expectations and spending signals can quickly swing sentiment. Investors are also recalibrating for 2026 after fresh color from the Fed on how comfortable policymakers are with further easing. The minutes are a detailed
Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

NEW YORK, December 30, 2025, 2:22 PM ET — Regular session Freeport-McMoRan shares rose about 0.5% to $51.75 in afternoon trading on Tuesday, after swinging between $50.87 and $52.67 earlier in the session. The move matters because Freeport’s earnings tend to track copper prices closely. When the metal rises, miners typically see higher revenue per pound sold, which can lift cash generation. Copper’s year-end rally has put the spotlight back on supply tightness and demand tied to electrification and the buildout of power-hungry data centers. That backdrop has helped keep interest in large, liquid copper names such as Freeport. U.S.
BETA Technologies stock slides in year-end trade: what’s driving the move and what investors watch next

BETA Technologies stock slides in year-end trade: what’s driving the move and what investors watch next

NEW YORK, December 30, 2025, 14:01 ET — Regular session Shares of BETA Technologies, Inc. (BETA) fell 3.4% to $28.46 in afternoon trading on Tuesday after opening at $29.82, leaving the stock near the day’s low of $28.37. The session high was $29.79, with about 304,000 shares traded. The drop came as U.S. stocks held near flat in choppy, holiday-thinned trading, with investors focused on minutes from the Federal Reserve’s Dec. 9-10 meeting due later in the day. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide.
Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

NEW YORK, December 30, 2025, 13:47 ET — Regular session Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) shares were down 3.6% at $67.09 at 1:47 p.m. ET on Tuesday, after trading between $65.94 and $69.95. The stock’s drop came as biotech weakened but the wider market held steady, a setup that can amplify moves in higher-volatility drug developers. The SPDR S&P Biotech ETF (XBI) fell 1.3% and the iShares Nasdaq Biotechnology ETF (IBB) dropped 1.1%, while the S&P 500 tracker SPY was flat and the Nasdaq-100 proxy QQQ edged higher. The timing matters because Arrowhead is heading into an early-January news window where
Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

NEW YORK, December 30, 2025, 13:43 ET — Regular session Shares of Energy Fuels Inc fell 3.5% to $14.55 in afternoon trading on Tuesday. The uranium miner lagged peers, with Uranium Energy down about 1.9% while Cameco was little changed and MP Materials slipped about 1.3%. Energy Fuels traded about 5.9 million shares and ranged between $14.30 and $15.28. The pullback matters because uranium stocks have been swinging on fresh evidence of supply discipline, contract signings and realized pricing. Investors want proof that producers can turn high commodity prices into durable cash flow, not just headlines. Energy Fuels is a
Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

NEW YORK, December 30, 2025, 13:30 ET — Regular session Rivian Automotive, Inc shares were down about 6% on Tuesday, pulling back in a light year-end session after a regulatory filing disclosed a stock sale by Chief Executive Officer Robert J. Scaringe. The move matters because thin holiday liquidity can exaggerate swings in high-volatility names, and investors have shifted back to demand signals and funding risk across electric-vehicle makers. Traders also had one eye on U.S. Federal Reserve minutes due later in the session and a closely watched Tesla update on quarterly deliveries, events that can reset risk appetite for
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

NEW YORK, December 30, 2025, 13:34 ET — Regular session Warby Parker Inc (WRBY) shares fell about 3.9% to $22.11 in early afternoon trading on Tuesday, after ending Monday at $23.00. The stock opened at $22.90 and traded between $21.87 and $23.13, with nearly 3 million shares changing hands; the company is valued at about $3.4 billion. The slide comes with just a handful of sessions left in 2025, a stretch when trading often thins out and price moves can look outsized. Thin trading means fewer buyers and sellers, so routine position changes can move a stock more than usual.
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

NEW YORK, December 30, 2025, 13:01 ET — Regular session Equinox Gold Corp shares rose about 2.2% on Tuesday, trading around $14.30, as a rebound in gold prices lifted the sector. The stock traded between $14.18 and $14.58, with about 2.2 million shares changing hands. The move matters because the gold market has turned choppy into year-end after a powerful run, and miners often magnify bullion swings. A small change in the gold price can quickly reshape expectations for miners’ cash flow. Investors are also positioning around the Federal Reserve’s December meeting minutes, due later Tuesday, for clues on how
1 296 297 298 299 300 585

Stock Market Today

Halma share price: Friday’s lift sets up what investors watch next week

Halma share price: Friday’s lift sets up what investors watch next week

7 February 2026
Halma shares closed up 0.7% at 3,548 pence on Friday, valuing the group at about £13.4 billion. The Bank of England held rates at 3.75% in a split vote, keeping rate-cut speculation in focus. Halma’s next trading update is set for March 12. The FTSE 100 ended the week up 0.6%, lifted by bank stocks.
Diageo share price slips into the weekend as investors eye Feb. 25 results

Diageo share price slips into the weekend as investors eye Feb. 25 results

7 February 2026
Diageo shares closed down 1.48% at 1,760 pence on Friday, trailing a 0.59% gain in the FTSE 100. An updated analyst consensus points to a 2.0% fall in first-half organic net sales ahead of interim results due Feb. 25. Trading volume was light, and the stock remains over 22% below its 52-week high.
National Grid share price: what to know before London reopens after BoE signal

National Grid share price: what to know before London reopens after BoE signal

7 February 2026
National Grid shares closed at 1,285 pence in London on Friday, up 0.23%. The Bank of England held rates at 3.75% after a close vote, signaling possible cuts if inflation falls. National Grid announced a wireless power transmission study with Space Solar and marked five years of IFA2 interconnector operations. Its U.S. ADR ended at $88.06, up $1.17.
BAE Systems share price rises into weekend — what to watch before Monday’s London open

BAE Systems share price rises into weekend — what to watch before Monday’s London open

7 February 2026
BAE Systems shares closed up 1.2% at 1,879 pence on Friday, tracking gains in European defence stocks. The company’s market value stands near £54.8 billion. Investors await BAE’s full-year results on Feb. 18 for updates on cash returns and orders. GXO Logistics renewed and expanded its contract to support BAE’s Type 26 frigate program in Scotland.
Go toTop